Table 2 Analyses of clinical characteristics of patients with postoperative complications assessed using the Clavien–Dindo classification
Univariate analysis | Multivariate analysis | |||||
|---|---|---|---|---|---|---|
Grade ≤ II | Grade ≥ III | p-value | Odds ratio (95% CI) | p-value | Odds ratio (95% CI) | |
N = 161 | N = 28 | |||||
General background | ||||||
Age | ||||||
Years | 75.0 (65–95) | 76.5 (67–92) | 0.206 | |||
≥ 80 years | 36 (22.4%) | 11 (39.3%) | 0.056 | 2.25 (0.97–5.23) | 0.088 | |
Sex | ||||||
Male | 100 (62.1%) | 25 (89.3%) | 0.005 | 5.08 (1.47–17.55) | 0.008 | 5.51 (1.55–19.57) |
Comorbidity | ||||||
Hypertension | 80 (49.7%) | 20 (71.4%) | 0.033 | 2.53 (1.05–6.08) | 0.094 | |
Diabetes mellitus | 41 (25.5%) | 6 (21.4%) | 0.648 | |||
Hyperlipidemia | 29 (18.0%) | 5 (17.9%) | 0.984 | |||
Cardiovascular | 22 (13.7%) | 4 (14.3%) | 0.563 | |||
Cerebrovascular | 14 (8.7%) | 4 (14.3%) | 0.266 | |||
Renal | 8 (5.0%) | 3 (10.7%) | 0.211 | |||
Hemodialysis | 4 (2.5%) | 1 (3.6%) | 0.556 | |||
Respiratory | 2 (1.2%) | 2 (7.1%) | 0.105 | |||
5-item modified frailty index | ||||||
≥ 2 | 35 (21.9%) | 10 (35.7%) | 0.113 | |||
Disease | ||||||
Malignant | 143 (88.8%) | 25 (89.3%) | 0.621 | |||
InBody 770 | ||||||
BMI (kg/m2) | 22.5 (14.6–37.6) | 21.9 (15.7–26.5) | 0.215 | |||
SMI | 6.6 (4.1–10.4) | 6.55 (5.3–8.3) | 0.538 | |||
Abnormal | 60 (37.3%) | 18 (64.3%) | 0.007 | 3.03 (1.31–6.99) | 0.023 | 2.78 (1.16–6.71) |
Body fat (%) | 26.3 (7.1–47.0) | 25.1 (9.0–40.0) | 0.569 | |||
Body cell mass (kg) | 26.8 (16.8–42.2) | 26.6 (22.1–34.3) | 0.871 | |||
SF-8 | ||||||
PCS score | 47.9 (18.6–59.2) | 46.5 (19.2–55.8) | 0.295 | |||
Abnormal | 34 (23.4%) | 9 (36.0%) | 0.182 | |||
MCS score | 48.8 (24.4–64.6) | 51.6 (20.0–64.7) | 0.291 | |||
Abnormal | 65 (44.8%) | 9 (36.0%) | 0.411 | |||
Blood pressure/pulse wave test | ||||||
CAVI | ||||||
Abnormal | 47 (29.2%) | 16 (57.1%) | 0.004 | 3.23 (1.42–7.36) | 0.019 | 2.81 (1.18–6.67) |